Clinical Trial Update: BNP Therapy Observation Unit Outcomes STudy (BOOST) [Phase 4]

View source ↗

Summary

A Phase 4 trial called BOOST evaluating BNP therapy for congestive heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BNP therapy (B-type natriuretic peptide)

Snippet

Sponsor: Emory University | Conditions: Congestive Heart Failure | Phase 4 | Status: TERMINATED